The Emerging Roles of N6-methyladenosine (m6A)-modified Long Non-coding RNAs in Human Cancers
Overview
Authors
Affiliations
N-methyladenosine (mA) epitranscriptional modifications widely exist in RNA, which play critical roles in RNA metabolism and biogenesis processes. Long non-coding RNAs (lncRNAs) are class of non-coding RNAs longer than 200 nucleotides without protein-coding ability. LncRNAs participate in a large number of vital biological progressions. With the great improvement of molecular biology, mA and lncRNAs are attracting more attention from researchers and scholars. In this review, we overview the current status of mA and lncRNAs based on the latest research, and propose some viewpoints for future research perspectives.
Ye X, Lin J, Chen Y, Wang X Front Immunol. 2024; 15:1480834.
PMID: 39606242 PMC: 11599169. DOI: 10.3389/fimmu.2024.1480834.
Epigenetics of Conjunctival Melanoma: Current Knowledge and Future Directions.
Flick K, Demirci H, Demirci F Cancers (Basel). 2024; 16(21).
PMID: 39518125 PMC: 11544918. DOI: 10.3390/cancers16213687.
N-methylation in the development, diagnosis, and treatment of gastric cancer.
Wang J, Zhao G, Zhao Y, Zhao Z, Yang S, Zhou A J Transl Int Med. 2024; 12(1):5-21.
PMID: 38525439 PMC: 10956730. DOI: 10.2478/jtim-2023-0103.
Mao Z, Wang B, Zhang T, Cui B Cell Death Dis. 2023; 14(11):734.
PMID: 37951987 PMC: 10640579. DOI: 10.1038/s41419-023-06265-2.